Optical coherence tomography: a window into the mechanisms of multiple sclerosis

[1]  Eliza M. Gordon-Lipkin,et al.  Reproducibility of optical coherence tomography in multiple sclerosis. , 2008, Archives of neurology.

[2]  R. Mccoll,et al.  A preliminary validation study of diffusion tensor imaging as a measure of functional brain injury. , 2008, Archives of neurology.

[3]  Amy Conger,et al.  Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. , 2008, Archives of neurology.

[4]  M. Ramanathan,et al.  Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis , 2008, Journal of the Neurological Sciences.

[5]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[6]  H. Weiner.  A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis , 2008, Journal of Neurology.

[7]  Wolfgang Drexler,et al.  State-of-the-art retinal optical coherence tomography , 2008, Progress in Retinal and Eye Research.

[8]  David H. Miller,et al.  An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. , 2007, Brain : a journal of neurology.

[9]  E. D. Schwartz,et al.  Relation of vision to global and regional brain MRI in multiple sclerosis , 2007, Neurology.

[10]  Eliza M. Gordon-Lipkin,et al.  Optical coherence tomography and disease subtype in multiple sclerosis , 2007, Neurology.

[11]  Eliza M. Gordon-Lipkin,et al.  Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis , 2007, Neurology.

[12]  Claire Paquet,et al.  Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2007, Neuroscience Letters.

[13]  J. De Keyser,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[14]  H P Hartung,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[15]  Fiona Costello,et al.  Quantifying axonal loss after optic neuritis with optical coherence tomography. , 2006, Annals of neurology.

[16]  D. Goodin.  IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event , 2006, Neurology.

[17]  M Filippi,et al.  Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. , 2006, Archives of neurology.

[18]  L. Balcer.  Clinical practice. Optic neuritis. , 2006, The New England journal of medicine.

[19]  D. Arnold,et al.  IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event , 2006, Neurology.

[20]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[21]  Gary R Cutter,et al.  Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. , 2006, Ophthalmology.

[22]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[23]  J. Duker,et al.  Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. , 2005, Ophthalmology.

[24]  Stephen J. Jones,et al.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis , 2005, Annals of neurology.

[25]  R. Rudick,et al.  Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis , 2005, Neurology.

[26]  D. Zee,et al.  The neuro-ophthalmology of multiple sclerosis , 2005, The Lancet Neurology.

[27]  Shuliang Jiao,et al.  Simultaneous acquisition of sectional and fundus ophthalmic images with spectral-domain optical coherence tomography. , 2005, Optics express.

[28]  Stephen J. Jones,et al.  A serial MRI study following optic nerve mean area in acute optic neuritis. , 2004, Brain : a journal of neurology.

[29]  J. Duker,et al.  Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. , 2004, Optics express.

[30]  J. M. Gordon.  The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee , 2004, Neurology.

[31]  Teresa C. Chen,et al.  In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. , 2004, Optics letters.

[32]  D. Goodin,et al.  The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. , 2004, Neurology.

[33]  G J Barker,et al.  Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.

[34]  M. Maguire,et al.  Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite , 2003, Neurology.

[35]  B. Bouma,et al.  Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. , 2003, Optics letters.

[36]  S. L. Galetta,et al.  The utility of MRI in suspected MS , 2003, Neurology.

[37]  Changhuei Yang,et al.  Sensitivity advantage of swept source and Fourier domain optical coherence tomography. , 2003, Optics express.

[38]  Makoto Nakamura,et al.  Evaluation of the Effect of Aging on Retinal Nerve Fiber Layer Thickness Measured by Optical Coherence Tomography , 2003, Ophthalmologica.

[39]  A. Fercher,et al.  Performance of fourier domain vs. time domain optical coherence tomography. , 2003, Optics express.

[40]  L. Pasquale,et al.  Scanning laser polarimetry of edematous and atrophic optic nerve heads. , 2003, Archives of ophthalmology.

[41]  A. Fercher,et al.  In vivo human retinal imaging by Fourier domain optical coherence tomography. , 2002, Journal of biomedical optics.

[42]  P. O'Suilleabhain,et al.  Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score , 2002, Journal of neurology, neurosurgery, and psychiatry.

[43]  M. Kupersmith,et al.  Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. , 2002, Brain : a journal of neurology.

[44]  C. Keeler.  The ophthalmoscope in the lifetime of Hermann von Helmholtz. , 2002, Archives of ophthalmology.

[45]  R. Leigh,et al.  Keeping an eye on MS , 2001, Neurology.

[46]  P. Kramer,et al.  MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis.11Neurology 2001;57:762–768. , 2001 .

[47]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[48]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[49]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[50]  F Pierelli,et al.  Correlation between morphological and functional retinal impairment in multiple sclerosis patients. , 1999, Investigative ophthalmology & visual science.

[51]  A. Fercher,et al.  Measurement of intraocular distances by backscattering spectral interferometry , 1995 .

[52]  E A Swanson,et al.  Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. , 1995, Archives of ophthalmology.

[53]  J. Fujimoto,et al.  Optical coherence tomography: A new tool for glaucoma diagnosis , 1995, Current opinion in ophthalmology.

[54]  J. Fujimoto,et al.  Optical coherence tomography of the human retina. , 1995, Archives of ophthalmology.

[55]  J. Duker,et al.  Imaging of macular diseases with optical coherence tomography. , 1995, Ophthalmology.

[56]  J. Fujimoto,et al.  In vivo retinal imaging by optical coherence tomography. , 1993, Optics letters.

[57]  A. Fercher,et al.  In vivo optical coherence tomography. , 1993, American journal of ophthalmology.

[58]  O. Périer,et al.  Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. , 1983, Journal of clinical neuro-ophthalmology.

[59]  F. Ikuta,et al.  Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States , 1976, Neurology.

[60]  L. Frisén,et al.  Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. , 1974, Archives of ophthalmology.

[61]  David H. Miller,et al.  Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. , 2008, Archives of neurology.

[62]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.

[63]  W R Green,et al.  RETINAL PATHOLOGIC CHANGES IN MULTIPLE SCLEROSIS , 1994, Retina.

[64]  J. Bogousslavsky,et al.  Nuclear and prenuclear syndromes of the oculomotor nerve , 1983 .